Gilead Sciences, Inc. (NASDAQ:GILD)  plans to present over 20 research abstracts—spanning both Gilead and its cell therapy unit Kite—at two major medical conferences: the 2025 ASCO Annual Meeting (May ...

Shares of Gilead Sciences Inc. GILD advanced 1.99% to $100.34 Thursday, on what proved to be an all-around great trading ...

Shares of Gilead Sciences Inc. GILD shed 2.30% to $101.43 Tuesday, on what proved to be an all-around mixed trading session ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Gilead Sciences, Inc.

BofA Securities Health Care Conference May 13, 2025 2:20 PM ET. Company Participants. Johanna Mercier – Chief Commercial Officer. Conference ...

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ ...

At Gilead, we innovate for impact. This commitment helps us drive scientific solutions forward, reach more people in more places and protect the planet we all share.